Early business entry of Zuellig to domestic drug markets unclear.

Published: 1999-04-06 17:32:00

Updated: 1999-04-06 17:32:00

Zuellig, a Swiss pharmaceutical wholesale company, planned to make a market entry into Korea during the first half of this year, but it seems to be very unclear, although they had tried to speed up their business launching in contact with many outstanding domestic drug wholesalers.

In the mean...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK